HE HUMAN PROTO-ONCOGENE c-kit encodes a transmembrane protein known as the receptor for the recently cloned stem cell factor (SCF) that is thought to play a critical role in the regulation of cell proliferation and differentiati~n."~ Studies on mice with mutations in the W locus showed several lesions in the c-kit gene leading to anemia, to mast cell deficiency and reduction of progenitors within various hematopoietic lineages, and to sterility and lack of pigmentation; the latter aspect suggested an important role for c-kit in hematopoiesi~?*~<~ This SCF receptor displaying tyrosine kinase activity was found to be highly expressed in various hematopoietic cells and in other tisthe proliferation of murine mast cells and to enhance the formation of granulocyte-macrophage colonies, erythroid bursts, and colonies of multipotential progenitor^.^"' The ckit ligand acted on the hematopoietic progenitor cells independently or synergistically with other factors such as interleukin-3 (IL-3), IL-6, IL-7, erythropoietin, granulocytemacrophage colony-stimulating factor (GM-CSF) and granulocyte-CSF (G-CSF). '2"5 It has been proposed that c-kit and its ligand might play a role in the pathogenesis of acute myeloid leukemia (AML).I6 Several recent studies provided confirmatory evidence for the hypothesis that c-kit and its ligand are involved in the clonogenic growth of AML b1a~ts.I~"~ However, clearly, less is known about the role of c-kit and SCF in human megakaryoblastic leukemia. Biologic studies on megakaryopoiesis and megakqocyte differentiation have been hampered by the scarcity of megakaryocytes in the bone m m w (BM), because human megakaryocytes constitute less than 1 % of the nucleated cells in the BM. In contrast to this heterogeneity of cellular components in primary material, cell lines provide the convenient advantage of a homogeneous, clonal cell population.
In the present study, we have investigated c-kit gene expression at the transcriptional level in a large panel of different continuous human leukemia-lymphoma cell lines using Northern blot analysis and reverse transcriptase-polymerase chain reaction (RT-PCR). We found that all megakaryoblastic leukemia cell lines expressed c-kit mRNA, most of them at high levels. To investigate whether expression of the SCF receptor is associated with the differentiation of human megakaryoblastic leukemia cells, we used protein ations, changes in the surface marker profile, and growth arrest. These effects were associated with enhanced c-kit mRNA expression. Exposure to all-trans retinoic acid downregulated c-kit mRNA levels, while simultaneously causing morphologic alterations in all four cell lines. Stimulation with growth factors (interleukin-3, granulocyte macrophagecolony stimulating factor, and insulin-like growth factors I and 11). used to assess any role of c-kit in proliferative processes, did not lead to signifiiant upregulation or downregulation of c-kit expression. The finding of constitutive and high expression of c-kitmRNA in all megakaryoblastic Ieukemia cell lines and its modulation by various reagents might further contribute to the understanding of megakaryopoietic proliferation, differentiation, and leukemogenesis. kinase C activators such as 12-0-tetradecanoylphorbol 13-acetate (TPA) and Bryostatin 1 (Bryo 1) as well as alltrans retinoic acid (ATRA) to induce several cell lines to differentiate to more mature stages. Furthermore, the hematopoietic cytokines IL-3, GM-CSF, insulin-like growth factor I (IGF-I), and IGF-I1 were applied in attempts to probe the effects of these molecules on c-kit gene expression during induced proliferation of megakaryoblastic cells.
MATERIALS AND METHODS

Cell Culture
Cell lines were grown in appropriate media (GIBCO, Eggenstein, Germany) supplemented with 10% to 20% heat-inactivated fetal calf serum (FCS; Sigma, Deisenhofen, Germany) at 37°C in an atmosphere of 5 % COz in air. Growth factor-dependent cell lines were cultured with the respective cytokines. The cells were examined daily in the culture flasks under an inverted microscope. All cultures were free of mycoplasma contamination. Cells were harvested in their logarithmic growth phase with viabilities of higher than 90% as examined by trypan blue exclusion.
In Vitro Treatment
The four megakaryoblastic leukemia cell lines, CMK,M DAMI?' M-07e:' and MKPL-l , 23 were used in experiments aimed at modulation of c-kit gene expression by inducers and growth factors. The cells were exposed to the following agents at 10" mom each: TPA (Sigma), Bryo 1 (kindly provided by Prof G.R. Pettit, Arizona Cancer Center, Tempe, M ) , and ATRA (Sigma). The reagents were 2134 HU ET AL 
Evaluation of Cell Proliferation
The methylthiotetrazole (MTT) assay was used to evaluate the proliferation of the megakaryoblastic cells. The use of MTT as an indicator of cell growth has been well Cells were grown in microtiter plates at a density of 2 X IO'lwell in the presence of the different inducers or growth factors mentioned above. The cells were pulsed for 4 hours with I O pL MTT solution [5 mglmL 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (Sigma) in phosphate-buffered saline (PBS)]. The reaction was stopped with 120 pL of 5% formic acid in isopropanol. The absorbances were measured at 570 nm with an enzyme-linked immunosorbent assay reader. Actual cell number counting was also used to measure the proliferation of the cells. Aliquots of cells were taken from each treatment group at the four time points (24, 48. 72, and 96 hours), and viable cells were enumerated after exposure to trypan blue. Results were expressed as percentage of untreated control cells.
Morphologic Evaluation
Aggregation and adhesion of the leukemia cells were examined in the culture wells or flasks under an inverted microscope. Morphologic features were reviewed on cytospin slide preparations stained with May-Griinwald-Giemsa stain.
Immunophenotyping Analysis
The cells were immunophenotyped using monoclonal antibodies (MoAbs) directed against the antigens CD13 (MY7; Coulter, Krefeld, Germany), CD14 (FMCI7; Flinders Medical Center, Melbourne, Australia), CD33 (MY9; Coulter), HLA-DR (RFDR-2; Royal Free Hospital, London, UK), CD4la (glycoprotein [GP] IlblIIIa; Dako, Hamburg, Germany), and CD42b (GP Ib; Dako). Briefly, in a microtiter plate system, the cells were washed twice with PBS and then incubated for 30 minutes with specific MoAbs at optimal dilutions. All reactions were examined with the indirect method: after incubation with MoAbs and subsequent washing steps, cells were stained for 45 minutes with fluorescein isothiocyanate-conjugated goat antimouse isotype-specific F(ab')' reagents (SBA, Dunn, Asbach, Germany). The labeled cells were analyzed by flow cytometry (FACScan; Becton Dickinson, Heidelberg, Germany). In every determination, a negative control of an irrelevant mouse MoAb of the same isotype as the MoAb under testing was included.
HU ET AL
Molecular Probes
The DNA fragments obtained from the recombinant plasmids carrying the gene sequences studied are c-kir (a 1.25-kb Sst I cDNA fragment cloned in pUCl19; obtained from American Type Culture Collection [ATCC; Rockville, MD])' and hamster 0-actin (a 1.25-kb Psr I fragment cloned in pBR322).
RNA Preparation and Northern Blot Analysis
For Northern blot analysis, total RNA was prepared using the guanidinium isothiocyanatelCsC1 method. Equal quantities of total RNA (10 pg) were separated on 1.0% formaldehyde agarose gels. The fractionated RNA was transferred to nylon filters that were subsequently cross-linked with UV light. The gels were stained with ethidium bromide to ensure that equal amounts of RNA were analyzed and that no degradation had occurred. After prehybridization at 60°C for 2 hours, the RNA was hybridized to nick-translated "PaCTP-labeled cDNA probes for 18 hours at 60°C. After stringent washing, the blots were exposed to x-ray films with an intensifying screen at -80°C. Sizes of mRNAs were estimated from the positions of 28s and 18s bands in ethidium bromide-stained blot gels. The same filters were subsequently hybridized with a 0-actin probe.
RT-PCR
First-strand cDNA was synthesized using a reverse transcriptase pmamplification system kit (Super Script; GIBCO) following the manufacturer's instructions. Five micrograms of total RNA as a template were incubated with 50 ng of random hexamer nucleotides in a final volume of 16 pL DEPC-H20. After heating the mixture at 70°C for IO minutes, I pL (200 U) of Moloney murine leukemia virus reverse transcriptase, 2 pL IOX synthesis buffer, and 1 pL of IO mmol/L dNTP mix were added to the reaction system. The reaction mixture was then incubated at 42°C for 50 minutes, at 90°C for 5 minutes and was then quickly chilled on ice. After brief centrifugation, 2 U RNase H were added to the reaction mixture, and this mixture was incubated for 20 minutes at 37°C to digest the template RNA.
Five microliters of the reverse transcriptase reaction mixture containing the first-strand cDNA were diluted with PCR buffer (IOX: 500 mmol/L KCI, 15 
The amplified PCR products were electrophoresed in 1.0% agarose gels, were stained with ethidium bromide, and were observed under UV light. Negative controls were included in each RT-PCR assay to exclude false-positive results. RT-PCR on RNA from the same sample was performed in tandem with the c-kir PCR using the housekeeping gene, &actin, to show that RNA was intact and amplifiable for the exclusion of false-negative results.
Detection of Apoptotic DNA Degradation For genomic DNA preparation, 5 X IO6 cells were harvested, washed twice with PBS (pH 7.3 , and incubated with lysis buffer overnight at 50°C. The samples were extracted twice with an equal volume of phenol-chloroform-isoamyl alcohol. The DNA was precipitated with 7.5 mom ammonium acetate and 100% ethanol, was treated with 1 ,ug/mL DNase-free RNase (Sigma) for 1 hour at 3 7 T , and was dissolved in buffer at a concentration of 1 ,ugh&. Apoptotic DNA degradation was examined by electrophoresing the DNA in a 1.6% agarose gel. DNA degradation was visible in the ethidium bromide-stained gel under UV light as a ladder of about 200-bp fragments.
RESULTS
Constitutive Expression of c-kit
c-kit mRNA expression detected by Northern blot analysis. To determine the pattern of c-kit expression in different cell lineages, we analyzed 164 continuous human leukemia and lymphoma cell lines using Northern blot analysis ( Table 1) . Northern blot analysis of total cytoplasmic RNA showed specific signals of 5 kb in size on probing with the human c-kit cDNA in positive cell lines. c-kit mRNA was not found in any cell line of the 54 lymphoid leukemia, 11 myeloma, or 28 lymphoma cell lines. c-kit mRNA was detected in 10 of 10 megakaryoblastic and in 6 of 8 erythroid leukemia cell lines; 7 of 29 myeloid and 1 of 24 monocytic leukemia cell lines were also positive for c-kit. These data indicate that ckit gene expression, as detectable by Northern blotting, is restricted to leukemia cell lines derived from myeloid, monocytic, erythroid, and megakaryoblastic lineages. Most of the 10 megakaryoblastic leukemia cell lines displayed large amounts of c-kit mRNA. Fig I shows Efsects of TPA, Bryo I and ATRA on cell proliferation. The MTT assay and cell counting were used to investigate the proliferation-inhibiting effects of P A , Bryo 1, and ATRA on the four megakaryoblastic leukemia cell lines. Growth inhibition was already clearly observed after 48 hours and became more pronounced at 72 and 96 hours (Fig  3) . Whereas TPA was the most effective reagent, the degree of inhibition varied between cell lines. Results from the MTT assay correlated well with the actual cell numbers enumerated by cell counting in a hematocytometer with trypan blue.
Effects of growth factors on cell proliferation. The effects of the cytokines IL-3, GM-CSF, IGF-I, and IGF-I1 on the growth of the four cell lines were also measured with the MTT assay and by cell counting. As shown in Fig 3, both IL-3 and GM-CSF strongly enhanced the proliferation of M-07e cells. IGF-I and IGF-I1 also stimulated the growth of M-07e cells, albeit to a lesser extent. Only IL-3 and GM-CSF increased the proliferation of CMK and MKPL-1, whereas IGF-I and IGF-I1 were not effective. DAMI cells did not respond to any of the four growth factors.
Morphologic analysis of induced cell lines. All four megakaryoblastic cell lines grow as suspension cultures with less than 5% of the population adhering to the plastic surface and extending pseudopods. During the 4-day treatment period, untreated cells did not show any signs of spontaneous morphologic changes. However, cells treated with the various inducers showed significant morphologic changes in all four cell lines. Within 4 hours of adding the PKC activators TPA and Bryo 1 or ATRA to the cell culture, the cell morphology began to change, leading to some significant alterations over the next 2 to 3 days (Fig 4) . In TPA-or Bryo l-treated cultures, more than 50% of the cells adhered to the surface of the flask and aggregated to form clusters. The cytoplasm increased, and the cell form became clearly more irregular. An increased number of giant cells was readily observed. In about 20% to 50% of CMK, DAMI, and MKPL-1 cells, we found polykaryons, some with more than five nuclei; the increased cytoplasm appeared as ruffled extensions. ATRA-treated cells, however, showed different changes in morphology. Only few cells adhered to the plastic surface; the increase of the cytoplasm was less abundant, but there was a prominent development of cytoplasmic budlike processes; and the blast-like nuclei became more dense. No morphologic changes were observed in the cultures exposed to L-3, GM-CSF, IGF-I, or IGF-11. The appearance of large cells with nuclei that are either segmented or fragmented was not caused by poor cell culture conditions because the viabilities were 80% or higher throughout the treatment period. plc of M-07e cells that were starved for 96 hours by withdrawing the S637 supernatant (containing GM-CSF and IL-3) clearly displayed the DNA degradation in the characteristic oligonucleosomal pattern (data not shown).
1mmurzo)~)henoty~)ing analysis .J' induced cell lines.
The surface marker protilcs of the four megakaryoblastic cell lines, before and after exposure to TPA, Bryo I , or ATRA, are summarized in Table 2 . Except for the negative M-07c cells, the cell lines showed the typical mcgakaryoblastic surface markers, GPIlb/IlIa (CD4 1 a) and GP Ib (CD42b). Treatment with TPA or Bryo 1 induced an upregulation of several surface antigens. A strong increase in the percentage of CD4la-and CD42b-positive cells was noticed in CMK, DAMI, and MKPL-l (Fig S) . To a certain extent, CD13, CD14, CD33, and HLA-DR expression was also increased in CMK, DAMI, and MKPL-I cells after treatment with TPA or Bryo 1 but not ATRA. ATRA, at I O ' mol/L, did not have any remarkable effects on the expression of those surface markers studied. In contrast to the other three megakaryoblastic cell lines, no major changes were seen in the M-07e immunoprofile throughout the 4-day treatment period when compared with that for the untreated cells.
Modulation of c-kit gene expression. mRNA was isolated from the cell lines after treatment with the differentiation inducers TPA, Bryo l , and ATRA or with the growth factors IL-3, GM-CSF, IGF-I and IGF-11. TPA and Bryo 1 upregulated c-kit expression in all four cell lines, with TPA being the more effective reagent of the two inducers and DAMI and MKPL-l being the most responsive cell lines (Fig   6) . Only a slight, but reproducible decrease in c-kit mRNA was noted in the four cell lines treated with ATRA; however, c-kit was not completely downregulated (Fig 6). IL-3 . GM-CSF, IGF-I, and IGF-I1 did not have any significant effects on the c-kit expression in the four cell lines (Fig 7) .
DISCUSSION
Recently, evidence has been presented that c-kit is also involved in the proliferation of human leukemia cells.'"'' M W  CD13  81  94  86  87  84  100  90  90  42  57  41  27  81  78  72  79   FMC17  CD14  46  79  63  49  30  91  63  58  0  7  0  0  28  52  21  17   MY9  CD33  83  85  90  90  100 100  95  100  40  47  48  38  86  82  76  75   GP Ilb/llla  CD4la  31  71  71  10  61  94  87  73  0  0  0  0  42  80  63  44   GP Ib  CD42b  6  42  46  8  70  87  86  73  8  22  20  9  0  29  28  9  RFDR-2  HLA-DR  11  50  27  20  80  96  88  90  0  15  4  0  42  57  37 between freshly explanted AML samples, most of which express c-kit mRNA and pr~tein,'~.'~.~' and established cell lines with the phenotypic characteristics of myeloid cells confirming a previous, albeit significantly smaller, study on c-kit expression in cell lines3' Short-term cultivation of primary AML blasts did not reduce c-kit expres~ion.~' One explanation might be that cell lines no longer need to express c-kit, having become entirely autonomous during establishment of the culture because of the outgrowth of a specific, independent clone.
After our initial studies that defined the category of cells expressing constitutively c-kit mRNA and that established the highest expression of c-kit in megakaryoblastic cell lines, we next examined whether c-kit mRNA is upregulated or downregulated during treatment with known differentiation inducers or with cytokines. We observed the following effects in all four cell lines, CMK, DAMI, M-07e, and MKPL-1, treated with TPA or Bryo 1: arrest of proliferation, distinct morphologic alterations, and changes in surface marker expression. The most remarkable changes were the increased number of giant cells with multilobulated or multiple nuclei, the segmentation and budding of the cytoplasm, and the increase in CD4la-and CD42b-positive cells. The morphologic alterations of megakaryoblastic cell lines triggered by TPA or Bryo 1 were paralleled by increases in c-kit mRNA levels.
ATRA slightly downregulated c-kit expression. The morphologic changes that were seen in ATRA-treated cells, including prominent development of cytoplasmic bud-like processes, do not necessarily constitute differentiation, especially in the face of no change in objective markers of megakaryocytic differentiation. Thus, from the data obtained, we cannot conclude unequivocally that differentiation occurred after ATRA treatment; alternatively, effects on the cell lines by ATRA may include programmed cell death (apoptosis) without differentiation or dedifferentiation. However, we excluded apoptotic DNA degradation in the two cell lines DAMI and M-07e. Therefore, depending on the type of modulators used and, consequently, the different signal transduction pathways, c-kit expression is augmented or reduced. The close relationship between erythroid and megakaryoblastic cell lines is underlined by the shared c-kit expression and by the fact that many of these cell lines carry markers of both lineages (eg, hemoglobin and CD4ld CD42b) or can be induced to mature along either pathway depending on the stimulus applied. Treatment with the cytokines, IL-3, GM-CSF, IGF-I, and IGF-11, increased cell proliferation significantly in M-07e cells but only marginally in the other three megakaryoblastic cell lines that normally grow independent of any growth factors. During exposure to these cytokines, c-kit mRNA levels did not change significantly. Further studies on primary cell material that could be more responsive to exogenous cytokines might be very informative for elucidating any potential role of c-kit in the regulation of megakaryoblastic proliferation. Tumor necrosis factor-cy enhanced c-kit mRNA expression in all specimens of primary AML (cases were classified as M 1, M2 and M4, but no cases of M7 were studied).29 These investigators did not find any positive effects of other cytokines on c-kit mRNA levels in AML cells, such as IL-6, GM-CSF and M-CSF. This is the first thorough study on the expression of c-kit in a large panel of well-characterized leukemia cell lines. A previous report addressed the expression of SCF mRNA and the mitogenic response to SCF protein in some 3 1 cell lines, most of which were also analyzed in the present report."
Using RT-PCR, SCF mRNA was detected in 17 of 26 cell lines (7 of 9 myeloid, 6 of 11 monocytic, 3 of 4 erythroid, and 1 of 2 megakaryoblastic cell lines according to our nomenclature). These data, together with the demonstration of SCF receptors on some cell lines, indicated the possibility of autocrine mechanisms in the growth of these cell lines. Only 5 of 27 cell lines showed a significant proliferative response to exogenously added SCF (2 of 9 myeloid, 0 of 11 monocytic, 2 of 4 erythroid, and 1 of 3 megakaryoblastic cell lines). It was concluded that the cells might already be maximally activated by the SCF present in FCS or by endogenously produced SCF. Interestingly, 4 of 5 SCF-responsive cell lines are growth factor-dependent cultures. Indeed, in these experiments, SCF synergized with IL-3, GM-CSF, and erythropoietin in inducing proliferation in the responsive cell lines.'y
In conclusion, our extended survey of leukemia-lymphoma cell lines representing all cell lineages showed the complete lack of c-kit mRNA expression in lymphoid leukemia or lymphoma cells. However, 15% and 50% of cell lines 
